Novo Nordisk (NVO) on Tuesday announced 14 new lawsuits filed against vendors selling cheaper compounded versions of its blockbuster medication semaglutide, marketed as Wegovy for patients with ...

Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss.

Noom introduces affordable options for obesity treatments, including Novo Nordisk's Wegovy and GLP-1Rx programs. Read more ...

Around 240,000 people are expected to be offered Mounjaro over the next three years, according to NICE, which has recommended ...

The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...

Novo Nordisk is attractively valued after the sell-off, but near-term recovery requires patience. Read why I'm downgrading ...

Novo Nordisk’s new weight-loss drug helped patients lose even more weight on average than its current Wegovy blockbuster treatment, an early-stage trial showed, as the drugmaker races to develop ...

Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

HYDERABAD, June 24 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO) on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli Lilly (LLY.N) began marketing ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped overweight and obese adults lose up to 24% of their weight as the Danish company ...

Demand for weight-loss and diabetes drugs seen global surge, CEO says move will come once patents begin to expire next year ...